Monash Vision Group (MVG) is a Melbourne-based collaborative partnership between Monash University and Alfred Health. MVG's primary goal is to develop a clinically viable cortical vision prosthesis - known as the Gennaris bionic vision system or "Gennaris" - which has been designed to bypass damage to the eye and optic nerve, to restore functional vision to people who have lost their sight through traumatic injury and conditions such as glaucoma and acquired retinal disease